Home/Filings/4/0000905148-25-001866
4//SEC Filing

Grant-Huerta Yanina 4

Accession 0000905148-25-001866

CIK 0001604464other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:59 PM ET

Size

4.9 KB

Accession

0000905148-25-001866

Insider Transaction Report

Form 4
Period: 2025-05-16
Grant-Huerta Yanina
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-05-16$6.76/sh2,218$15,00037,067 total
Footnotes (2)
  • [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2025 and May 19, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0002064348

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:59 PM ET
Size
4.9 KB